However, further study with other GCS inhibitors such as eliglustat, which is used for Gaucher’s disease in a clinical setting, and in vivo experiments are needed to clarify the significant role of GCS for chemoresistance in CCA. This evidence concerns the gene UGCG and cholangiocarcinoma.